Accessibility List

Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal has submitted to BSE the Shareholding Pattern f...

16-Apr-2026|3:30PM

As of March 2026, 68.85% is owned by Indian Promoters and 31.15% by Public.

Hikal - Retirement

14-Apr-2026|3:27PM

Hikal Limited has informed the Exchange about Retirement

Hikal - Announcement under Regulation 30 (LODR)-Retir...

14-Apr-2026|3:16PM

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015- Superannua

Hikal - Reply to Clarification- Financial results

13-Apr-2026|4:34PM

The Exchange had sought clarification from Hikal Limited for the quarter en

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug92.12261.20
Aarti Drug387.903,540.36
Aarti Pharma766.206,946.20
Abbott India26,700.0056,735.64
Accent Micro470.001,127.48
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
ICICI P..58.830.93
Tata Sm..48.540.50
Motilal..0.020.04
Bandhan..0.010.04
Motilal..0.000.00
More

Board Meetings

DatePurpose
11/02/2026Quarterly Results &..
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
04/02/2025Quarterly Results &..
More